The prevalence of thromboembolic events among COVID-19 patients admitted to a single centre intensive care unit (ICU): an epidemiological study from a Malaysian population

Introduction Thromboembolic (TE) complications in COVID-19 patients are rising globally, contributing significantly to mortality, particularly in severe cases. However, their prevalence, characteristics, and impact on mortality in Malaysia remain unclear.Objectives This study aimed to determine the...

Full description

Saved in:
Bibliographic Details
Main Authors: Nur Farhani Mansor, Izzati Abdul Halim Zaki, Lee Chew Kiok, Eng Kar Seng, Tharmini Ravi, Mohan Pathmanathan, Khang Wen Goh, Long Chiau Ming, Pakhrur Razi, Hanis Hanum Zulkifly
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Journal of Pharmaceutical Policy and Practice
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/20523211.2024.2449044
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832098354993037312
author Nur Farhani Mansor
Izzati Abdul Halim Zaki
Lee Chew Kiok
Eng Kar Seng
Tharmini Ravi
Mohan Pathmanathan
Khang Wen Goh
Long Chiau Ming
Pakhrur Razi
Hanis Hanum Zulkifly
author_facet Nur Farhani Mansor
Izzati Abdul Halim Zaki
Lee Chew Kiok
Eng Kar Seng
Tharmini Ravi
Mohan Pathmanathan
Khang Wen Goh
Long Chiau Ming
Pakhrur Razi
Hanis Hanum Zulkifly
author_sort Nur Farhani Mansor
collection DOAJ
description Introduction Thromboembolic (TE) complications in COVID-19 patients are rising globally, contributing significantly to mortality, particularly in severe cases. However, their prevalence, characteristics, and impact on mortality in Malaysia remain unclear.Objectives This study aimed to determine the prevalence of thromboembolic (TE) events and associated mortality among COVID-19 patients admitted within a single centre intensive care unit (ICU). The proportions of patients with TE events who died, and factors associated with TE events were explored.Methods In this retrospective cohort study, patients with PCR confirmed SARS-CoV-2 virus and who received thromboprophylaxis within February 2020–2021 were included. TE event is a combination of venous [(deep vein thrombosis (DVT), pulmonary embolism (PE)] and arterial (myocardial infarction (MI), stroke) thromboembolism.Results Mean (SD) age 56.6 (13.7), 63.5% were male, 61.6% Malays, median (IQR) 7 (3–14) days of ICU stay, 64.2%, 53.2% and 20.9% had underlying hypertension, diabetes and obesity respectively. In total, 240 (44.9%) developed TE event. Significantly higher proportions of COVID-19 patients who developed complications of DVT (2.5% vs. 0.2%; p = 0.013), PE (47.5% vs 34.0%; p = 0.006), stroke (12.3% vs. 1.5; p<0.001) and MI (16.4% vs. 4.6%; p<0.001) died. Predictors of TE events were age [HR 1.01 (95% CI 1.00–1.02)], obesity [HR 1.98 (95% CI 1.51–2.6)], D-dimer [HR 1.01 (95% CI 1.00–1.01)], and duration of ICU stay [HR 0.98 (95% CI 0.97–0.99)].Conclusion In severely ill COVID-19 patients, TE complications were common, and patients with DVT, PE, stroke, or MI faced increased mortality, even with thromboprophylaxis. Age, obesity, elevated D-Dimer levels, and longer ICU stays were significant predictors of TE events. Considering these findings, a more aggressive approach, combining thromboprophylaxis with enhanced anti-inflammatory treatments, may be necessary for high-risk COVID-19 ICU patients to reduce TE events and mortality.
format Article
id doaj-art-c4a8cde1c915420ea79d2ed52d4ebad8
institution Kabale University
issn 2052-3211
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Pharmaceutical Policy and Practice
spelling doaj-art-c4a8cde1c915420ea79d2ed52d4ebad82025-02-05T11:21:34ZengTaylor & Francis GroupJournal of Pharmaceutical Policy and Practice2052-32112025-12-0118110.1080/20523211.2024.2449044The prevalence of thromboembolic events among COVID-19 patients admitted to a single centre intensive care unit (ICU): an epidemiological study from a Malaysian populationNur Farhani Mansor0Izzati Abdul Halim Zaki1Lee Chew Kiok2Eng Kar Seng3Tharmini Ravi4Mohan Pathmanathan5Khang Wen Goh6Long Chiau Ming7Pakhrur Razi8Hanis Hanum Zulkifly9Pharmacy Department, Kuala Lumpur Hospital, Kuala Lumpur, MalaysiaFaculty of Pharmacy, Universiti Teknologi MARA, UiTM Kampus Puncak Alam, Puncak Alam, MalaysiaAnesthesiology and Intensive Care Department, Sungai Buloh Hospital, Sungai Buloh, MalaysiaAnesthesiology and Intensive Care Department, Sungai Buloh Hospital, Sungai Buloh, MalaysiaClinical Research Center, Sungai Buloh Hospital, Sungai Buloh, MalaysiaInstitute for Clinical Research, National Institutes of Health, Shah Alam, MalaysiaFaculty of Data Science and Information Technology, INTI International University, Nilai, MalaysiaSchool of Medical and Life Sciences, Sunway University, Sunway City, MalaysiaCenter of Disaster Monitoring and Earth Observation, Physics Department, Universitas Negeri Padang, Padang, IndonesiaFaculty of Pharmacy, Universiti Teknologi MARA, UiTM Kampus Puncak Alam, Puncak Alam, MalaysiaIntroduction Thromboembolic (TE) complications in COVID-19 patients are rising globally, contributing significantly to mortality, particularly in severe cases. However, their prevalence, characteristics, and impact on mortality in Malaysia remain unclear.Objectives This study aimed to determine the prevalence of thromboembolic (TE) events and associated mortality among COVID-19 patients admitted within a single centre intensive care unit (ICU). The proportions of patients with TE events who died, and factors associated with TE events were explored.Methods In this retrospective cohort study, patients with PCR confirmed SARS-CoV-2 virus and who received thromboprophylaxis within February 2020–2021 were included. TE event is a combination of venous [(deep vein thrombosis (DVT), pulmonary embolism (PE)] and arterial (myocardial infarction (MI), stroke) thromboembolism.Results Mean (SD) age 56.6 (13.7), 63.5% were male, 61.6% Malays, median (IQR) 7 (3–14) days of ICU stay, 64.2%, 53.2% and 20.9% had underlying hypertension, diabetes and obesity respectively. In total, 240 (44.9%) developed TE event. Significantly higher proportions of COVID-19 patients who developed complications of DVT (2.5% vs. 0.2%; p = 0.013), PE (47.5% vs 34.0%; p = 0.006), stroke (12.3% vs. 1.5; p<0.001) and MI (16.4% vs. 4.6%; p<0.001) died. Predictors of TE events were age [HR 1.01 (95% CI 1.00–1.02)], obesity [HR 1.98 (95% CI 1.51–2.6)], D-dimer [HR 1.01 (95% CI 1.00–1.01)], and duration of ICU stay [HR 0.98 (95% CI 0.97–0.99)].Conclusion In severely ill COVID-19 patients, TE complications were common, and patients with DVT, PE, stroke, or MI faced increased mortality, even with thromboprophylaxis. Age, obesity, elevated D-Dimer levels, and longer ICU stays were significant predictors of TE events. Considering these findings, a more aggressive approach, combining thromboprophylaxis with enhanced anti-inflammatory treatments, may be necessary for high-risk COVID-19 ICU patients to reduce TE events and mortality.https://www.tandfonline.com/doi/10.1080/20523211.2024.2449044COVID-19intensive care unitthromboembolic complicationsmortalityhuman and diseasechronic respiratory disease
spellingShingle Nur Farhani Mansor
Izzati Abdul Halim Zaki
Lee Chew Kiok
Eng Kar Seng
Tharmini Ravi
Mohan Pathmanathan
Khang Wen Goh
Long Chiau Ming
Pakhrur Razi
Hanis Hanum Zulkifly
The prevalence of thromboembolic events among COVID-19 patients admitted to a single centre intensive care unit (ICU): an epidemiological study from a Malaysian population
Journal of Pharmaceutical Policy and Practice
COVID-19
intensive care unit
thromboembolic complications
mortality
human and disease
chronic respiratory disease
title The prevalence of thromboembolic events among COVID-19 patients admitted to a single centre intensive care unit (ICU): an epidemiological study from a Malaysian population
title_full The prevalence of thromboembolic events among COVID-19 patients admitted to a single centre intensive care unit (ICU): an epidemiological study from a Malaysian population
title_fullStr The prevalence of thromboembolic events among COVID-19 patients admitted to a single centre intensive care unit (ICU): an epidemiological study from a Malaysian population
title_full_unstemmed The prevalence of thromboembolic events among COVID-19 patients admitted to a single centre intensive care unit (ICU): an epidemiological study from a Malaysian population
title_short The prevalence of thromboembolic events among COVID-19 patients admitted to a single centre intensive care unit (ICU): an epidemiological study from a Malaysian population
title_sort prevalence of thromboembolic events among covid 19 patients admitted to a single centre intensive care unit icu an epidemiological study from a malaysian population
topic COVID-19
intensive care unit
thromboembolic complications
mortality
human and disease
chronic respiratory disease
url https://www.tandfonline.com/doi/10.1080/20523211.2024.2449044
work_keys_str_mv AT nurfarhanimansor theprevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT izzatiabdulhalimzaki theprevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT leechewkiok theprevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT engkarseng theprevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT tharminiravi theprevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT mohanpathmanathan theprevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT khangwengoh theprevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT longchiauming theprevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT pakhrurrazi theprevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT hanishanumzulkifly theprevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT nurfarhanimansor prevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT izzatiabdulhalimzaki prevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT leechewkiok prevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT engkarseng prevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT tharminiravi prevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT mohanpathmanathan prevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT khangwengoh prevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT longchiauming prevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT pakhrurrazi prevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation
AT hanishanumzulkifly prevalenceofthromboemboliceventsamongcovid19patientsadmittedtoasinglecentreintensivecareuniticuanepidemiologicalstudyfromamalaysianpopulation